• 1. Estimates of hydride ion stability in condensed systems: energy of formation and solvation in aqueous and polar-organic solvents
  Craig A. Kelly,David R. Rosseinsky Phys. Chem. Chem. Phys., 2001,3, 2086-2090
• 2. Evolutionary approaches in protein engineering towards biomaterial construction
  Brindha J.,Balamurali M. M.,Kaushik Chanda RSC Adv., 2019,9, 34720-34734
• 3. Dissociative dynamics of O2 on Ag(110)?
  Ivor Lon?ari? Phys. Chem. Chem. Phys., 2015,17, 9436-9445
• 4. Excellent humidity sensor based on ultrathin HKUST-1 nanosheets?
  Qiaoe Wang,Meiling Lian,Xiaowen Zhu,Xu Chen RSC Adv., 2021,11, 192-197
• 5. Evidence of CO2 molecule acting as an electron acceptor on a nanoporous metal–organic-framework MIL-53 or Cr3+(OH)(O2C–C6H4–CO2)?
  Alexandre Vimont,Arnaud Travert,Philippe Bazin,Jean-Claude Lavalley,Marco Daturi,Christian Serre,Gérard Férey,Sandrine Bourrelly,Philip L. Llewellyn Chem. Commun., 2007, 3291-3293

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Thiophenes 2,3,5-trisubstituted thiophenes

Introduction to 3,5-dichlorothiophene-2-carbaldehyde (CAS No. 67482-51-3) and Its Emerging Applications in Chemical Biology

3,5-dichlorothiophene-2-carbaldehyde, identified by the Chemical Abstracts Service Number (CAS No.) 67482-51-3, is a heterocyclic compound that has garnered significant attention in the field of chemical biology due to its versatile structural framework and reactivity. This organosulfur derivative belongs to the thiophene family, characterized by a sulfur-containing five-membered aromatic ring, which makes it a valuable scaffold for synthesizing complex molecules with potential biological activities. The presence of both chlorine substituents at the 3rd and 5th positions, along with the aldehyde functional group at the 2nd position, enhances its utility as a building block in medicinal chemistry and material science.

The aldehyde group in 3,5-dichlorothiophene-2-carbaldehyde serves as a reactive handle for further functionalization through condensation reactions, such as Schiff base formation, or as a precursor for introducing other pharmacophores. This reactivity has been exploited in the development of novel therapeutic agents targeting various diseases. Recent studies have highlighted its role in designing small-molecule inhibitors for enzymes involved in metabolic pathways and cancer signaling cascades.

In the realm of chemical biology, 3,5-dichlorothiophene-2-carbaldehyde has been employed to synthesize derivatives with antimicrobial and anti-inflammatory properties. The chlorine atoms at the 3rd and 5th positions contribute to electron-withdrawing effects, which can modulate the electronic properties of the thiophene ring, influencing its interactions with biological targets. For instance, researchers have utilized this compound to develop novel antibiotics by leveraging its ability to disrupt bacterial cell wall synthesis or inhibit key enzymatic pathways.

Moreover, the structural motif of 3,5-dichlorothiophene-2-carbaldehyde has found applications in the field of organic electronics. The thiophene ring is a well-known component in conductive polymers and organic semiconductors due to its ability to facilitate charge transport. By incorporating chlorine atoms and an aldehyde group, scientists have been able to fine-tune the electronic properties of these materials for use in optoelectronic devices such as organic light-emitting diodes (OLEDs) and solar cells. The aldehyde functionality also allows for further cross-coupling reactions, enabling the construction of more complex molecular architectures with enhanced performance characteristics.

Recent advancements in medicinal chemistry have demonstrated the potential of 3,5-dichlorothiophene-2-carbaldehyde as a key intermediate in the synthesis of kinase inhibitors. Kinases are enzymes that play crucial roles in cell signaling pathways, and their dysregulation is often associated with diseases such as cancer. By designing molecules based on this scaffold, researchers have been able to develop potent inhibitors that selectively target specific kinases without affecting others. This approach has led to the discovery of several lead compounds that are currently undergoing preclinical evaluation.

The versatility of 3,5-dichlorothiophene-2-carbaldehyde extends to its role in developing fluorescent probes for cellular imaging. The conjugation of thiophene derivatives with fluorophores has enabled researchers to visualize biological processes with high precision. For example, derivatives of this compound have been used to track protein-protein interactions or monitor metabolic activity within cells. The chlorine substituents can be tailored to enhance photostability or improve solubility, making these probes more suitable for in vivo applications.

In conclusion, 3,5-dichlorothiophene-2-carbaldehyde (CAS No. 67482-51-3) represents a multifaceted compound with broad applications across chemical biology and material science. Its unique structural features—comprising a thiophene ring substituted with chlorine atoms and an aldehyde group—make it an invaluable tool for synthesizing biologically active molecules and advanced materials. As research continues to uncover new functionalities and applications for this compound, its significance in drug discovery and technological innovation is expected to grow further.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)